INR 653.35
(2.19%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 29.76 Billion | -30.57 Billion | 10.1 Billion | 9.29 Billion | 9.5 Billion | 2.06 Billion |
Net Income | 24.41 Billion | 12.42 Billion | 16.15 Billion | 14.56 Billion | 2.85 Billion | 3.84 Billion |
Depreciation & Amortization | 825.8 Million | 583.8 Million | 482.6 Million | 472.7 Million | 397.1 Million | 239.5 Million |
Deferred income taxes | - | -3.6 Billion | -7.11 Billion | -8.39 Billion | 1.26 Billion | 1.19 Billion |
Stock-based compensation | 249.3 Million | 290.4 Million | 240.4 Million | 198.6 Million | 109.8 Million | 189.7 Million |
Change in working capital | 16.54 Billion | -40.3 Billion | 306.8 Million | 2.41 Billion | 4.84 Billion | -3.39 Billion |
Other non-cash items | -21.71 Billion | 36 Million | 29 Million | 37.1 Million | 34.2 Million | -6.7 Million |
Investing Cash Flow | -31.01 Billion | -2.87 Billion | -4.47 Billion | -2.76 Billion | -3.52 Billion | 39.1 Million |
Investments in PPE | -1.5 Billion | -1.67 Billion | -545.4 Million | -646.7 Million | -699.2 Million | -265.9 Million |
Acquisitions | - | 1.29 Billion | 4.96 Billion | 2.11 Billion | 2.84 Billion | -398.69 Million |
Investment purchases | -5.4 Billion | -4.82 Billion | -11.12 Billion | -5.87 Billion | -5.87 Billion | -71.64 Billion |
Sales/Maturities of investments | 4.28 Billion | 3.53 Billion | 6.16 Billion | 3.73 Billion | 3.02 Billion | 71.93 Billion |
Other Investing Activities | 54.2 Million | -1.19 Billion | -3.92 Billion | -2.08 Billion | -2.82 Billion | 410.39 Million |
Financing Cash Flow | 33.01 Billion | 37.84 Billion | 2.82 Billion | -2.04 Billion | -1.27 Billion | -1.42 Billion |
Debt repayment | -3.78 Billion | -41.2 Billion | -17.18 Billion | -45.2 Million | -5.3 Billion | -1.65 Billion |
Dividends payments | -2.52 Billion | -1.48 Billion | -867.3 Million | -289.4 Million | -1.56 Billion | -1.52 Billion |
Common Stock Repurchased | - | -1.98 Billion | -927.8 Million | -1.48 Billion | 5.3 Billion | 1.65 Billion |
Common Stock Issuance | 772.8 Million | 106.4 Million | 339.8 Million | 151.4 Million | 403.9 Million | 182.6 Million |
Other Financing Activities | 401.6 Million | 82.4 Billion | 21.46 Billion | 48.9 Million | -123.3 Million | -80.7 Million |
Accounts receivables | -9.27 Billion | -414.8 Million | -1.12 Billion | -1.81 Billion | 7.57 Billion | -4.8 Billion |
Accounts payables | 20.61 Billion | -2.52 Billion | 6.75 Billion | 12.27 Billion | 4.07 Billion | 702.3 Million |
Inventory | - | 2.52 Billion | -6.75 Billion | -12.27 Billion | -4.07 Billion | -702.3 Million |
Other working capital | 5.2 Billion | -39.88 Billion | 1.42 Billion | 4.22 Billion | -2.73 Billion | 1.4 Billion |
Cash at beginning of period | 25.76 Billion | 21.37 Billion | 12.92 Billion | 8.43 Billion | 3.73 Billion | 3.05 Billion |
Cash at end of period | 120.71 Billion | 25.76 Billion | 21.37 Billion | 12.92 Billion | 8.43 Billion | 3.73 Billion |
Capital Expenditure | -1.5 Billion | -1.67 Billion | -545.4 Million | -646.7 Million | -699.2 Million | -265.9 Million |
Effect of forex changes on cash | - | - | - | 500 Thousand | - | - |
Net cash flow / Change in cash | 94.94 Billion | 4.38 Billion | 8.45 Billion | 4.48 Billion | 4.69 Billion | 678.8 Million |
Free Cash Flow | 28.25 Billion | -32.25 Billion | 9.56 Billion | 8.64 Billion | 8.8 Billion | 1.79 Billion |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 8.81 Billion | 24.41 Billion | 7.23 Billion | 6.59 Billion | 5.31 Billion | 5.26 Billion |
Depreciation & Amortization | - | 825.8 Million | - | 240.3 Million | 172.6 Million | 173.5 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | 249.3 Million | 249.3 Million | - | - | - |
Change in working capital | - | 16.54 Billion | - | - | - | - |
Other non-cash items | -8.81 Billion | -21.71 Billion | -7.48 Billion | -6.59 Billion | -5.31 Billion | -5.26 Billion |
Investing Cash Flow | - | -31.01 Billion | - | - | - | - |
Investments in PPE | - | -1.5 Billion | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | -5.4 Billion | - | - | - | - |
Sales/Maturities of investments | - | 4.28 Billion | - | - | - | - |
Other Investing Activities | - | 54.2 Million | - | - | - | - |
Financing Cash Flow | - | 33.01 Billion | - | - | - | - |
Debt repayment | - | -3.78 Billion | - | - | - | - |
Dividends payments | - | -2.52 Billion | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 772.8 Million | - | - | - | - |
Other Financing Activities | - | 401.6 Million | - | - | - | - |
Accounts receivables | - | -9.27 Billion | - | - | - | - |
Accounts payables | - | 20.61 Billion | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | 5.2 Billion | - | - | - | - |
Cash at beginning of period | - | 25.76 Billion | - | 108.99 Billion | 108.64 Billion | 25.76 Billion |
Cash at end of period | - | 120.71 Billion | - | 109.47 Billion | 108.99 Billion | 26.11 Billion |
Capital Expenditure | - | -1.5 Billion | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 94.94 Billion | - | 480.6 Million | 345.2 Million | 347 Million |
Free Cash Flow | - | 28.25 Billion | - | 480.6 Million | 345.2 Million | 347 Million |
SVRS
300326
002119
RXMD
MOREPENLAB
GBLX